Feb 15, 2024 / 06:30AM GMTOperator Good afternoon, ladies and gentlemen. I am Soumya, moderator for the conference call. Welcome to Valiant Organics Limited Q3
Ahead of its listing, shares of Valiant Organics were commanding a premium Rs 20 per equity share in the grey market, suggesting a listing pop of around 15 per cent over the issue.
Valiant Laboratories IPO |that focuses on manufacturing Paracetamol intends to raise Rs 152.46 crore via public issue at the upper price band, which comprises only a fresh issue component.
Valiant Laboratories IPO: The firm is planning to raise Rs 152.46 crore via initial public offering, at the upper price band. The offer consists of only a fresh issue of 1.09 crore equity shares by the company.
Valiant Laboratories IPO: The initial public offering comprises only a fresh issue of 1.09 crore equity shares by the company and there is no offer-for-sale portion in the issue.
Bharat Dynamics signs Rs 290.90 cr contract with IAF; Zydus Lifesciences gets EIR report from USFDA; Lemon Tree Hotels launches 8th property in Uttarakhand; Dr. Madhu Sasidhar appointed as Chief Strategy Officer of Apollo Hospitals; Tata Motors to increase prices of commercial vehicles by 3%; RBI approves re-appointment of Sashidhar Jagdishan as MD & CEO of HDFC Bank; Jio launches AirFiber services; Kajaria Ceramics enters into JV with UK Parts; LJIN Electronics forms JV with Nexxbase; Mindtree launches Testing as a Service for Oracle SaaS; Biocon appoints Peter Bains as Group CEO; TARC to issue Rs 191 cr NCDs; Welspun to liquidate part of assets; Varroc Engineering to sell plant & machineries; Valiant Organics files RHP for IPO; Sasken to invest in AI/5G/Power IP licensing; Captain Pipes to set up greenfield plant; Prakash Industries gets EC for Bhaskarpara Coal Mine; WPIL gets Rs 14.3 cr order from MoD; Indo Amines acquires land; NBCC gets Rs 150 cr order; JK Lakshmi Cement to source solar power; B & A to acquire Moheema Tea Estate; DCM Shriram enters into strategic collaboration; Sundaram Multi Pap to sell non-core asset; Mawana Sugars gets SEBI show cause notice. #Business #Contracts #Investments #Launches #Appointments #Orders #IPO #JVs #Clearances #Stoppages #AssetSale #SolarPower #ShowCauseNotice
Firms in aniline derivatives market capture steady revenues from demand from multiple industries, particularly medical plastics; uptake of N,N-Dimethyl...
After an extremely negative week, the key benchmark indices were seen fluctuating between gains and losses in Monday's trading session. The BSE Sensex gyrated between zones, and was up 100-odd points at 51,470, the NSE Nifty 50 reclaimed 15,300-level.
Indian equity markets came off day's highs after turning positive as the Reserve Bank of India (RBI) retained the FY23 GDP growth forecast at 7.2 per cent. Sectorally, Banks, Financials, Metals, PSBs and Realty indices held strong gains on the Nifty. While, Auto, Pharma, FMCG and Consumer Durables were subdued.
Based on the open interest future percentage, here are the 82 stocks including JK Cement, Deepak Nitrite, Shree Cements, Dalmia Bharat, and ACC, in which a short build-up was seen.